Compliance and Administration Technique in Topical Drug Therapy of Glaucoma

This study has been completed.
Sponsor:
Information provided by:
University of Toronto
ClinicalTrials.gov Identifier:
NCT00303121
First received: March 14, 2006
Last updated: October 10, 2006
Last verified: June 2006
  Purpose

Clinic-based evaluation of patients compliance with topical medications in the treatment of glaucoma. Also assessing effectiveness of delivery techniques among these patients.


Condition
Glaucoma

Study Type: Observational
Study Design: Observational Model: Defined Population
Time Perspective: Cross-Sectional

Resource links provided by NLM:


Further study details as provided by University of Toronto:

Estimated Enrollment: 120
Study Start Date: November 2005
Estimated Study Completion Date: June 2006
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

glaucoma 18 years of age or older

Exclusion Criteria:

Recent ocular surgery

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00303121

Locations
Canada, Ontario
Toronto Western Hospital
Toronto, Ontario, Canada, M5T 2S8
Sponsors and Collaborators
University of Toronto
Investigators
Principal Investigator: Yvonne M Buys, MD University of Toronto
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00303121     History of Changes
Other Study ID Numbers: UHN REB 05-0631-AE
Study First Received: March 14, 2006
Last Updated: October 10, 2006
Health Authority: Canada: Ethics Review Committee

Keywords provided by University of Toronto:
Glaucoma
Compliance
Therapy
Administration technique

Additional relevant MeSH terms:
Glaucoma
Ocular Hypertension
Eye Diseases

ClinicalTrials.gov processed this record on July 22, 2014